DK1021719T3 - Fremgangsmåde til påvisning af antistoffer i en pröve - Google Patents

Fremgangsmåde til påvisning af antistoffer i en pröve

Info

Publication number
DK1021719T3
DK1021719T3 DK98948398T DK98948398T DK1021719T3 DK 1021719 T3 DK1021719 T3 DK 1021719T3 DK 98948398 T DK98948398 T DK 98948398T DK 98948398 T DK98948398 T DK 98948398T DK 1021719 T3 DK1021719 T3 DK 1021719T3
Authority
DK
Denmark
Prior art keywords
sample
detecting antibodies
present
assays
universal
Prior art date
Application number
DK98948398T
Other languages
English (en)
Inventor
David Y Chien
Phillip Arcangel
Stephen Tirell
Wanda Ziegler
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK1021719T3 publication Critical patent/DK1021719T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/82Hepatitis associated antigens and antibodies
DK98948398T 1997-09-22 1998-09-22 Fremgangsmåde til påvisning af antistoffer i en pröve DK1021719T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5970397P 1997-09-22 1997-09-22
US8392198P 1998-05-01 1998-05-01
PCT/US1998/019693 WO1999015898A1 (en) 1997-09-22 1998-09-22 Method for detecting antibodies in a sample

Publications (1)

Publication Number Publication Date
DK1021719T3 true DK1021719T3 (da) 2007-06-18

Family

ID=26739077

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98948398T DK1021719T3 (da) 1997-09-22 1998-09-22 Fremgangsmåde til påvisning af antistoffer i en pröve

Country Status (12)

Country Link
US (1) US6391540B1 (da)
EP (1) EP1021719B1 (da)
JP (1) JP4124961B2 (da)
AT (1) ATE354800T1 (da)
AU (1) AU9497998A (da)
CA (1) CA2303123C (da)
CY (1) CY1107621T1 (da)
DE (1) DE69837155T2 (da)
DK (1) DK1021719T3 (da)
ES (1) ES2281934T3 (da)
PT (1) PT1021719E (da)
WO (1) WO1999015898A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
DK1295126T3 (da) * 1999-07-28 2007-04-10 Novartis Vaccines & Diagnostic Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
DE10006432A1 (de) * 2000-02-14 2001-08-16 Ganzimmun Inst Fuer Ganzheitli Verfahren zum Nachweis von Helicobacter pylori in Stuhl- und Speichelproben
CN100463922C (zh) * 2000-06-15 2009-02-25 诺华疫苗和诊断公司 抗hcv抗体的免疫测定
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
CN1946856A (zh) * 2004-04-15 2007-04-11 美国联合生物公司 检测病毒感染的方法和装置
JP5414667B2 (ja) 2007-05-08 2014-02-12 エフ.ホフマン−ラ ロシュ アーゲー 特異的免疫グロブリンクラスg抗体の検出方法
CN105486856A (zh) * 2015-12-24 2016-04-13 泰州泽成生物技术有限公司 一种定性检测丙型肝炎抗体的试剂盒及其制备方法和应用
CN107167584B (zh) * 2017-05-27 2020-03-03 北京热景生物技术股份有限公司 化学发光免疫分析仪
JP7198932B2 (ja) * 2018-09-18 2023-01-04 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド ジカウイルスイムノアッセイの方法および試薬

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556840B1 (fr) * 1983-12-16 1987-12-24 Immunotech Sa Procede de dosage in vitro des immunoglobulines specifiques d'un ou plusieurs allergenes et reactifs et moyens pour la mise en oeuvre de ce procede
US4737453A (en) 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
DE68907996T2 (de) 1988-05-11 1994-01-05 Abbott Lab Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests.
US5656426A (en) 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
BR9106309A (pt) * 1990-04-04 1993-04-20 Chiron Corp Combinacao de antigenos sinteticos de hepatite c viral (hcv),processo de detectar anticorpos para o virus da hepatite c e estojo para realizar teste
EP0473065A3 (en) * 1990-08-29 1992-08-26 Abbott Laboratories Simultaneous assay for detecting two or more analytes
EP0556331A4 (en) * 1990-11-09 1994-10-12 Abbott Lab AMPLIFIED HETEROGENIC CHEMILUMINESCENCE IMMUNOASSAY.
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ebna抗体の測定方法および抗ebna抗体測定キット
AU3422993A (en) 1992-01-06 1993-08-03 Dade International Inc. Multi-test immunochemical reagent and method to use same
JPH06213895A (ja) * 1992-10-16 1994-08-05 Evernew Biotec Inc C型肝炎の急性期の決定方法
US5395752A (en) 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
CA2137786A1 (en) 1993-04-14 1994-10-27 Murex Diagnostics Corporation Immunoassay
KR100312534B1 (ko) 1993-04-28 2002-05-13 성재갑 씨(c)형간염및비(b)형간염동시측정면역블롯검정키트및면역블롯검정법
ES2231773T3 (es) * 1993-05-05 2005-05-16 Common Services Agency Virus de la hepatitis c de tipo 4, 5 y 6.
WO1994026932A1 (en) 1993-05-13 1994-11-24 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nucleic acid tagged immunoassay
DE19502386A1 (de) 1995-01-26 1996-08-01 Boehringer Mannheim Gmbh Stabilisierung von Peptiden und Polypeptiden in immunologischen Tests durch Zusatz von kleinen Hitzeschockproteinen
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
EP0935662B1 (en) * 1996-05-24 2005-11-30 Chiron Corporation Multiple epitope fusion protein

Also Published As

Publication number Publication date
JP4124961B2 (ja) 2008-07-23
US6391540B1 (en) 2002-05-21
WO1999015898A1 (en) 1999-04-01
CA2303123A1 (en) 1999-04-01
ATE354800T1 (de) 2007-03-15
EP1021719B1 (en) 2007-02-21
JP2001517797A (ja) 2001-10-09
EP1021719A1 (en) 2000-07-26
AU9497998A (en) 1999-04-12
CA2303123C (en) 2006-04-11
DE69837155T2 (de) 2007-06-21
CY1107621T1 (el) 2013-03-13
ES2281934T3 (es) 2007-10-01
DE69837155D1 (de) 2007-04-05
PT1021719E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
ATE339688T1 (de) Diagnostische tests und kits für clostridium difficile
DE69719057T2 (de) Verfahren zur signalverstärkung
ES2168310T3 (es) Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido.
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
DK0811165T3 (da) Detektion af antistofproduktion
DE69632826D1 (de) Nukleinsaeure erkennung von hepatitis gb virus
BR9100924A (pt) Linha de celulas de hibridoma,mutantes,anticorpos,processo para a preparacao de uma linha de celulas de hibridoma,processo para a preparacao de anticorpos,processo e agente para a prova imunologica de metolacloro,derivado de metolacloro e processo para sua preparacao
DE60038557D1 (en) Assay
DK230485D0 (da) Fremgangsmaade til bestemmelse af atl virusantistof og reagens dertil
ATE285075T1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts
DK0788595T3 (da) Fremgangsmåde til undersögelse af immumkompetance
NO931613L (no) Fremgangsmaate for bestemming av sensiteten og/eller det spesifikke ved et proberingssystem for sporing av antistoffer